AI and predictive modeling to understand an individual’s immune system function and predict treatment response are still in very early stages. We dream about precision medicine and getting every answer we can for ourselves when we get sick. However, if we look at genomics, only about 20 percent of human coding genes are well-studied. The remaining 80 percent (about 16,000 genes, along with the proteins they make) are largely a mystery.
In this episode, you will hear more about the field of immuno-oncology, understand the correlation between tumor development and immune system response, and trends in cancer detection and prevention, especially liquid biopsies - tests for detecting tumors in blood samples.
Speaker: Brian Hashemi - Executive Chairman and CEO of Novigenix - a Swiss-based biotech company using AI and RNA sequence analysis to capture the cancer immunity cycle during the multi-stage disease progression and response to therapy.
www.facesofdigitalhealth.com
https://fodh.substack.com/
Show notes:
[00:02:00] The use of AI and RNA sequence analysis in capturing the cancer immunity cycle and disease progression
[00:04:00] Biotech in Switzerland
[00:06:00] The impact of Swiss biotech capabilities on global healthcare and the specific advancements made by Swiss companies in the field.
[00:08:00] Predictions and hopes for the future of healthcare technology, especially in the realms of cancer detection and treatment.
[00:10:00] Challenges and opportunities in biotech, and the role of AI in advancing healthcare.
[00:12:00] Challenges in Colorectal Cancer Screening
[00:14:00] The Impact of Liquid Biopsy on Clinical Trials and Drug Development
[00:16:00] Market Adoption and Patient Accessibility to Liquid Biopsy Tests
[00:18:00] The Future of Liquid Biopsy and Precision Medicine
[00:20:00] Real-world Application and Impact of Novel Biomarkers
[00:22:00] Expanding the Reach of Novel Diagnostics Beyond Switzerland
[00:24:00] Partnerships and Collaborations to Accelerate Adoption
Learning From pan-Canadian Health Data Strategy - What's Next to EHDS? (Eric Sutherland)
Healthtech in the GCC Countries: Focus on Infrastructure and Export Capabilities
DTx in 2024: Where Are We With Business and Reimbursement Models? (Andy Molnar)
What Factors Should You Take into Account when Designing ePROs - Electronic Patient Reported Outcomes Solutions?
DTx in Belgium: It's Time to Embed Digital Therapeutics in Clinical Pathways
In the Rapid Advancements in Oncology Treatments, How Can Healthcare IT Support Clinicians? (Elekta)
How Do Pharma and Digital Health Converge in 2024? (Amir Lahav)
Experience Economy: How To Create Healthcare Events the HLTH Way (Richard Scarfo)
Gender Impact On Health Is Huge - Women's Health Research Needs More Investments
How Can We Reduce Unnecessary Lab Testing?
Innovation at Charité, The Problems With DiGAs and the German Market (Dorothée Marie-Louise Döpfer)
The Rise of Non-Traditional Prescribers in the US and the role of ePrescribing
"Women's Health Space Is Not Doing Much Better Today Than 10 years Ago" (Marija Butkovic)
Why Human Connection Is Medicine, and How is Tech an Enabler
US and Europe: A Snapshot of Healthcare Innovation (Jody Tropeano, Henry Stoneley, HLTH)
How To Get Patient Feedback That Is Actionable
Upside Down: How AI Changed Healthcare in 2023
Not Just Women's Health: Trends in Fertility Tech (Leslie Schrock)
How Does AI Work For Medical Note Taking and Risk Scoring? (Augmedix, HDAI)
Create your
podcast in
minutes
It is Free
Insight Story: Tech Trends Unpacked
Zero-Shot
Fast Forward by Tomorrow Unlocked: Tech past, tech future
The Unbelivable Truth - Series 1 - 26 including specials and pilot
A Prairie Home Companion: News from Lake Wobegon